Bionomics Debt To Equity from 2010 to 2024

BNOX Stock  USD 0.30  0.02  7.14%   
Bionomics Debt To Equity yearly trend continues to be fairly stable with very little volatility. Debt To Equity will likely drop to 0 in 2024. Debt To Equity is a measure of a company's financial leverage calculated by dividing its total liabilities by stockholders' equity, indicating the proportion of equity and debt the company is using to finance its assets. View All Fundamentals
 
Debt To Equity  
First Reported
2010-12-31
Previous Quarter
0.003261
Current Value
0.003098
Quarterly Volatility
0.39901663
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bionomics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bionomics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 412.7 K, Interest Expense of 19 K or Other Operating Expenses of 18.8 B, as well as many indicators such as Price To Sales Ratio of 152.7 K, Dividend Yield of 0.0 or PTB Ratio of 0.56. Bionomics financial statements analysis is a perfect complement when working with Bionomics Valuation or Volatility modules.
  
Check out the analysis of Bionomics Correlation against competitors.

Latest Bionomics' Debt To Equity Growth Pattern

Below is the plot of the Debt To Equity of Bionomics Ltd ADR over the last few years. It is a measure of a company's financial leverage calculated by dividing its total liabilities by stockholders' equity, indicating the proportion of equity and debt the company is using to finance its assets. Bionomics' Debt To Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bionomics' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 0.01 %10 Years Trend
Slightly volatile
   Debt To Equity   
       Timeline  

Bionomics Debt To Equity Regression Statistics

Arithmetic Mean0.45
Geometric Mean0.11
Coefficient Of Variation89.19
Mean Deviation0.30
Median0.51
Standard Deviation0.40
Sample Variance0.16
Range1.265
R-Value(0.45)
Mean Square Error0.14
R-Squared0.20
Significance0.09
Slope(0.04)
Total Sum of Squares2.23

Bionomics Debt To Equity History

2024 0.003098
2023 0.003261
2020 0.002835
2019 0.9
2018 1.03
2017 1.27
2016 0.46

About Bionomics Financial Statements

Bionomics investors use historical fundamental indicators, such as Bionomics' Debt To Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bionomics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bionomics Stock Analysis

When running Bionomics' price analysis, check to measure Bionomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionomics is operating at the current time. Most of Bionomics' value examination focuses on studying past and present price action to predict the probability of Bionomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionomics' price. Additionally, you may evaluate how the addition of Bionomics to your portfolios can decrease your overall portfolio volatility.